Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Pricing snapshots
Regulatory databases
Product category trackers
Regulatory reports
Market reports
Infographics
Market Snapshots
News analysis
Flavour & nicotine trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Norway Ministry of Health introduces new national tobacco strategy…
  • New York - United States Bill introduced relating to the advertising and misrepresentation of e-cigs…
  • United States House committee accuses CTP of ‘fostering uncertainty’…
  • Slovenia Consultation ends on bill to ban flavours…
  • Germany Notifications list updated…
  • Louisiana - United States Bill aims to ban all flavours bar tobacco…
  • Brazil Banned or legal? Status of e-cigs to be settled ‘this year’…
  • Germany Untaxed e-liquids seized after retailers’ transitional period ends…
  • Egypt Health ministry warns strongly against e-cigarettes…
  • Netherlands Figures show sharp rise in vaping by young people…
  • United States Juul and Altria face trial over alleged marketing of e-cigs to kids…
  • Switzerland Study reveals level of e-cig use by 15-year-olds…
View all
News analysis

‘95% safer’ or ‘just as bad’? How does the argument on vaping stand?

Written by || 4th May 2020 || News analysis || Health and science | Policy and Politics | Europe France Italy North America United Kingdom United States

Widely publicised linkages with the coronavirus are just the latest manifestation of distrust of vaping, in the public-health community as well as the media. So how does that “95% safer than smoking” view hold up? ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

COP8 fails to bring parties together on the crucial risk/benefit question
PHE reiterates endorsement of vaping despite US lung illness outbreak
WHO’s anti-vaping stance needs to change says harm reduction report
Study urges caution on legalising e-cigarettes to cut smoking rates
Science clears conventional vaping of blame for lung disease horrors
Public Health England blames the media for giving vaping a bad name